Cargando…
Inhibitory Effect of Probenecid on Osteoclast Formation via JNK, ROS and COX-2
Probenecid is a representative drug used in the treatment of gout. A recent study showed that probenecid effectively inhibits oxidative stress in neural cells. In the present study, we investigated whether probenecid can affect osteoclast formation through the inhibition of reactive oxygen species (...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Applied Pharmacology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939694/ https://www.ncbi.nlm.nih.gov/pubmed/31474032 http://dx.doi.org/10.4062/biomolther.2019.047 |